[
    "**Protocol",
    "I: Procedure for knock-in/knock-out in cultured cells using the VIKING method**",
    "**Day 1: Cell culture**",
    " \u2022  Incubate HaCaT or human embryonic kidney 293F \\(HEK293F) cells in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum and 1 U/mL penicillin-streptomycin \\(D10 medium).",
    "\\(see Remark 2).",
    "**Day 2: Transfection \\(Fig.",
    "1a)",
    "**",
    "- Electroporation method \\(HaCaT cells)",
    " \u2022  Suspend cells in 400 \u00b5L Opti-MEM.",
    " ",
    "\u2022  ",
    "Transfect cells with the VIKING module and the target genome cleavage vector using a total of 15 \u00b5g DNA \\(molar ratio of donor cleavage vector \\(VKG1-gRNA-pX330):donor vector \\(pVKG1-PURO):target genome cleavage vector \\(pX330) = 1:1:17) using an electroporator.",
    " ",
    "\u2022  Transfer cells to 100 mm dishes and culture in D10 medium lacking antibiotics for 24 h.",
    "- Lipofection method \\(HEK293F cells).",
    " ",
    "\u2022  Suspend cells in 400 \u00b5L Opti-MEM.",
    " ",
    "\u2022  ",
    "Transfect cells with the VIKING module and the target genome cleavage vector using a total of 15 \u00b5g DNA \\(molar ratio of donor cleavage vector \\(VKG1-gRNA-pX330):donor vector \\(pVKG1-PURO):target genome cleavage vector \\(pX330) = 1:1:17) using TurboFect transfection reagent.",
    " ",
    "\u2022  Transfer cells to 100 mm dishes and culture in D10 medium lacking antibiotics for 24 h.",
    " \\(see Remark 3).",
    "**Day 4: Selection**",
    " \u2022  Refresh D10 medium.",
    " ",
    "\u2022  ",
    "Add puromycin \\(0.3 \u00b5g/mL) to the D10 medium and culture cells for 1\u20132 weeks.",
    "**Day 14:",
    "Clone picking \\(Fig.",
    "1b)",
    "**",
    " \u2022  Wash cells with phosphate-buffered saline.",
    " ",
    "\u2022  ",
    "Place the cloning ring on a single colony.",
    "Pick at least 20 colonies.",
    "Limiting dilution is also possible\uff0e",
    " \u2022  Add 20 \u00b5L trypsin to each ring.",
    " ",
    "\u2022  Incubate cells at 37\u00baC for 2 min \\(HEK293F cells) or 10 min \\(HaCaT cells).",
    " ",
    "\u2022  Transfer cells to a 24-well or 48-well plate.",
    " ",
    "\u2022  Incubate cells at 37\u00baC for several days.",
    " ",
    "\u2022  Transfer cells to a 12-well plate and incubate.",
    " ",
    "\u2022  Isolate a portion of the cells for DNA extraction.",
    "**Day 16: DNA extraction**",
    " \u2022  Add 180 \u00b5L of 50 mM NaOH and transfer to a 1.5 \u00b5L tube.",
    " ",
    "\u2022  Incubate at 95\u00baC for 30 min.",
    " \u2022  Add 20 \u00b5L of 1 M Tris HCl, pH 8.0.",
    " ",
    "\u2022  Centrifuge at 12,000 rpm for 10 min.",
    " \u2022  Transfer the supernatant to a new tube.",
    "**Day 17: Genotyping \\(confirmation of knock-in by PCR) \\(Fig.",
    "1c)**",
    "Knock-in and random insertion are confirmed by PCR using the extracted DNA as a template \\(see Remark 4 and 5). ",
    "There is no need for a special polymerase.",
    "GoTaq polymerase is used in this protocol.",
    "- Design primers to amplify the VKG1 sequence.",
    "Example:",
    "Primer 1 \\(VKG 1_4561 F), 5'-GCCTATGGAAAAACGCCAGC-3'.",
    "Primer 2 \\(VKG 1_250 R), 5'-TTCCTGTCTAGCGGTACGCG-3'.",
    "- Design primers that specifically bind to the target genome sequence.",
    "Example:",
    "Primer 3 \\(VDR genome_del 3 F), 5'-GGTGGGCCTCATGTCTTCTG-3'.",
    "Primer 4 \\(VDR genome_del 1 R), 5'-CCTTCATCATGCCGATGTCC-3'.",
    "**Genotyping by PCR**",
    " \u2022 PCR sample",
    "2\u00d7 GoTaq GreenMaster Mix, 12.5 \u00b5L",
    "10 \u00b5M Primer A, 2.5 \u00b5L",
    "10 \u00b5M Primer B, 2.5 \u00b5L",
    "Nuclease-free water, 6.5 \u00b5L",
    "Genomic DNA, 1 \u00b5L",
    "Total, 25 \u00b5L",
    " \u2022 Thermocycle",
    "95\u00baC for 2 min.",
    "30 cycles of 95\u00b0C for 30 sec, 55\u00b0C for 1 min, and 72\u00b0C for 2 min.",
    "72\u00baC for 4 min.",
    "12\u00baC hold.",
    "Step 1.",
    "Confirm random insertion.",
    "PCR is performed using Primer 1 and Primer 2 for Amplicon1.",
    "Random insertion is confirmed by amplification of Amplicon1.",
    "Step 2.",
    "Confirm knock-in at the target locus.",
    "- Forward direction",
    "PCR is performed using Primer 1 and Primer 3 for Amplicon2, or Primer 2 and Primer 4 for Amplicon3.",
    "Knock-in in the forward direction is confirmed by amplification of Amplicon2 and Amplicon3.",
    "- Reverse direction",
    "PCR is performed using Primer 2 and Primer 3 for Amplicon4, or Primer 1 and Primer 4 for Amplicon5.",
    "Knock-in in the reverse direction is confirmed by amplification of Amplicon4 and Amplicon5.",
    "**Protocol II: Procedure for knock-in in cultured cells using the VIKING method \\(Fig.",
    "2)**",
    "**Day 1\u201316**",
    "Same as Protocol I.",
    "**Day 17: Genotyping**",
    "- Design primers to amplify the VKG1 sequence.",
    "Same as Protocol I.",
    "- Design primers to amplify the VKG1 sequence.",
    "Example:",
    "Primer 1 \\(pEN_ObLi_40_For), 5'-TACCGCCTTTGAGTGAGCTG-3'.",
    "Primer 2 \\(pEN_ObLi_190_Rev), 5'-AAACCTGTCGTGCCAGCTGC-3'.",
    "- Design primers that specifically bind to the target genome sequence.",
    "Example:",
    "Primer 3 \\(AAVS_F5), 5'-GGAAATGGGGGTGTGTCACC-3'.",
    "Primer 4 \\(AAVS_R6), 5'-CCCTACCCCCCTTACCTCTC-3'.",
    "**Genotyping by PCR**",
    "Same as Protocol I. ",
    "**Remarks**",
    "1.",
    "This vector is selected according to the target locus for knock-in.\r\n  ",
    "2.",
    "In addition to HaCaT and HEK293F cells, the VIKING method has been validated in the C4-2 \\(human prostate cancer), UMR-106 \\(rat osteogenic), and MC3T3-E1 \\(mouse preosteoblastic) cell lines.",
    "3.",
    "These two transfection methods are examples and should be changed depending on cell lines to attain a high transfection efficiency.\r\n  ",
    "4.",
    "The backbone of the donor vector is integrated into the genome in principle.\r\n  ",
    "5.",
    "Tandem insertions of the donor vectors sometimes occur."
]